# Allogene Therapeutics, Inc.: Form 8-K, filed May 28, 2026

- Company: [Allogene Therapeutics, Inc.](/companies/allo.md) (CIK 1737287)
- Form: 8-K
- Filed: 2026-05-28
- Accepted by EDGAR: May 28, 2026, 17:06 ET
- Period: 2026-05-28
- Accession: 0001193125-26-245484
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737287/000119312526245484/d65280d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737287/000119312526245484/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737287/000119312526245484/d65280d8k.htm

Filed May 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-245484. Last ingested by Listed: Nov 10, 2026, 16:34 ET. No prices; not investment advice.